Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Donor-derived Cell Free DNA as a Potential New Biomarker in Cardiac Transplantation: Role in Acute Rejection

NCT04973943 is registered in ClinicalTrials.gov with Puerta de Hierro University Hospital as lead sponsor.

NCT NCT04973943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04973943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Donor-derived Cell Free DNA as a Potential New Biomarker in Cardiac Transplantation: Role in Acute Rejection
Lead sponsor
Puerta de Hierro University Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 19, 2019
Completion date
April 30, 2022
Enrollment
200 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

heart transplant rejection